Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) EBT (2019 - 2025)

Historic EBT for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$18.1 million.

  • Korro Bio's EBT rose 1402.8% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.4 million, marking a year-over-year decrease of 68.7%. This contributed to the annual value of -$83.5 million for FY2024, which is 290.22% down from last year.
  • According to the latest figures from Q3 2025, Korro Bio's EBT is -$18.1 million, which was up 1402.8% from -$25.8 million recorded in Q2 2025.
  • Over the past 5 years, Korro Bio's EBT peaked at $6.2 million during Q4 2022, and registered a low of -$25.8 million during Q2 2025.
  • Moreover, its 5-year median value for EBT was -$21.0 million (2024), whereas its average is -$19.7 million.
  • As far as peak fluctuations go, Korro Bio's EBT skyrocketed by 12886.32% in 2022, and later plummeted by 50976.63% in 2023.
  • Over the past 5 years, Korro Bio's EBT (Quarter) stood at -$21.5 million in 2021, then skyrocketed by 128.86% to $6.2 million in 2022, then plummeted by 509.77% to -$25.4 million in 2023, then grew by 16.79% to -$21.2 million in 2024, then increased by 14.63% to -$18.1 million in 2025.
  • Its last three reported values are -$18.1 million in Q3 2025, -$25.8 million for Q2 2025, and -$23.4 million during Q1 2025.